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ABSTRACT  
Objective: Application of nanotechnology in drug delivery system has released leading new areas of research in sustained release of drugs. The 
objective of the present study is development and optimization of polymeric nanoparticles of Nateglinide (NTG).  
Methods: Nateglinide loaded ethyl cellulose (EC) nanoparticles were prepared by the solvent evaporation technique. Response surface 
methodology (RSM) using the Box-Behnken design was used to optimize the formulation of Nateglinide nanoparticles. The Box-Behnken design 
consisting of 14 runs, three-factor, three levels and two centre point was used in this study. The particle size, zeta potential and entrapment 
efficiency of Nateglinide nanoparticles were investigated with respect to three independent variables including stirring speed (X1), time (X2) and 
surfactant concentration (X3
Results: Nateglinide nanoparticles under the optimized conditions gave rise to the DL of 14.30±0.27 %, EE of 72.19±0.24 %, mean diameter of 172 
nm and zeta potential value of-15.6 mV.  
). The optimized nanoparticle is then subjected to characterization studies including morphology, particle size, zeta 
potential, % Drug Loading (DL) and % Entrapment Efficiency (EE).  
Conclusion: The optimized nanoparticles formulation with improved characteristic properties could be a promising delivery system for 
Nateglinide. 
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INTRODUCTION 
Nanoparticles represent an effective nano carrier platform for the 
delivery of hydrophobic and hydrophilic drugs, since the drugs are 
protected from possible degradation by enzymes. The development 
of smart nanoparticles can deliver drugs at a sustained rate 
providing better efficacy and lower toxicity for treatment of various 
diseases [1]. Recently, nanoparticle engineering processes have been 
developed and reported for pharmaceutical applications to increase 
the dissolution rate of low-soluble drugs which in turn may leads to 
substantial increases in bioavailability and are essential for 
pharmaceutical industry as an alternative drug delivery system for 
the treatment of highly prevalent and chronic disease like diabetes 
mellitus [2].  
 
 
Fig. 1: Chemical structure of nateglinide 
 
Diabetes mellitus is a metabolic disease characterized by high blood 
glucose level resulting from defects in insulin secretion, insulin 
action or both [3]. Nateglinide (NTG) has been exploited as a new 
class of oral antidiabetic agent used in the management of Type 2 
diabetes mellitus. Nateglinide, (-)-N-[(trans-4-isopropyl-
cyclohexane) carbonyl]-D-phenylalanine, is structurally (fig. 1) 
unrelated to the oral sulfonylurea insulin secretagogues. Nateglinide 
is a D-phenylalanine derivative recently approved for the 
management of type II diabetes [4, 5]. In difference to sulfonylureas, 
Nateglinide increases pancreatic β cell sensitivity to ambient glucose 
without increasing basal insulin secretion after oral administration. 
It can be used as mono therapy or in combination with metformin or 
thiazolidinediones. It has short half-life of 1.5 h, and peak plasma 
concentration extents at 0.5-1.0 hr. It is metabolized by cytochrome 
P-450 system to inactive metabolite and eliminated with half-life of 
1.4 h [6].  
In the development of nanoparticles, an important issue was to 
design an optimized pharmaceutical formulation with maximum 
drug loading (DL), entrapment efficiency (EE) and appropriate mean 
particle size through minimum trials. For this purpose, a computer 
aided optimization technique based on a Response Surface 
Methodology (RSM) was used. Response surface methodology is a 
collection of mathematical and statistical techniques based on the fit 
of a polynomial equation to the experimental data, which must 
describe the behaviour of a data set with the objective of making 
statistically significant. It can be well applied when a response or a 
set of responses of interest is influenced by several variables. The 
objective is to simultaneously optimize the levels of these variables 
to attain the best system performance. The optimization procedure 
involved systematic formulation designs to minimize the number of 
trials, and analyse the response surfaces in order to realize the 
effects of causal factors and to obtain the appropriate formulations 
with target goals. Therefore, in order to quickly obtain the optimal 
formulations with appropriate drug loading (DL), entrapment 
efficiency (EE) and mean particle size of Nateglinide nanoparticles, 
RSM was used to evaluate the effects of stirring speed (X1), time (X2) 
and surfactant concentration (X3
The objective of the study was to fabricate and optimize ethyl 
cellulose nanoparticles containing Nateglinide to overcome the 
limitations of the Nateglinide delivery through conventional method. 
). Box-Behnken designs are 
response surface designs, specially made to require only 3 levels, 
coded as-1, 0, and+1. Box-Behnken designs are available for 3 to 10 
factors. They are formed by combining two-level factorial designs 
with incomplete block designs. This procedure creates designs with 
desirable statistical properties but, most importantly, with only a 
fraction of the experiments required for a three-level factorial. 
Because there are only three levels, the quadratic model is 
appropriate [7, 8].  
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MATERIALS AND METHODS 
Materials 
Nateglinide was obtained from Glanmark Pharmaceutics Ltd, 
Mumbai, India. Ethyl cellulose was received from Himedia 
Laboratories, Mumbai, India. Polyvinyl alcohol was procured from 
Fourrts India Laboratories Pvt Ltd, Chennai, India. Methanol 
(Qualigens Fine Chemicals, Mumbai) was of high performance liquid 
chromatography (HPLC) grade. All other reagents and solvents were 
of analytical grade.  
Preparation of Nateglinide nanoparticles 
The NTG-loaded EC nanoparticles were prepared by the solvent 
evaporation method. Briefly, weighed NTG and EC were dissolved in 
mixture of methanol with acetone in 1:2 ratio using a vortex shaker 
(to mix small vials of liquid) to form the homogeneous organic phase 
of NTG and EC. This solution was added drop by drop into the 1 % 
aqueous phase of polyvinyl alcohol using mechanical stirrer at 1000 
rpm for 2 h to prepare nano suspension and thoroughly evaporate 
the organic phase followed by magnetic stirring for 2 hrs under 
atmospheric pressure at room temperature. Then it was centrifuged 
at 15,000 rpm for 15 minutes and after centrifugation the 
supernatant was excreted and the pellets obtained were washed 
thrice with distilled water and finally freeze-dried to get the 
powdered nanoparticles [9, 10].  
Experimental design 
Preliminary experiments indicated that the variables, such as 
stirring speed, time and surfactant concentration were the main 
factor that affects the particle size, zeta potential and entrapment 
efficiency of nanoparticles.  
Thus, a response surface methodology-Box Behnken design was 
used to systemically investigate the influence of these three critical 
formulation variables on particle size, zeta potential and entrapment 
efficiency. The details of the design are listed in the table 1. For each 
factor, the experimental range was selected based on the results of 
preliminary experiments and the feasibility of preparing the 
nanoparticles at the extreme values. The range of independent 
variables and their corresponding levels of actual values are given 
below. 
 
Table 1: Independent variables and their corresponding levels of NTG-loaded EC nanoparticles preparation for Box-Behnken 
Variables Levels 
-1 0 +1 
Stirring speed (rpm) 500 750 1000 
Time (min) 1 2 3 
Surfactant concentration (%) 1 1.5 2 
 
Characterisation 
Particle size and zeta potential measurement  
Particle size of fabricated nanoparticles was measured by particle 
size analyser (MASTERSIZER 2000, MALVERN Instruments, UK) 
equipped with MAS OPTION particle sizing software. The 
measurements were made at a fixed angle of 90 ° for all samples. 
The samples were suitably diluted with Milli Q water for every 
measurement. Zeta potential measurements were measured by 
Malvern zeta sizer (MAL 1054413 Zetasizer Version 6.20 
Instruments, UK). For zeta potential determination, samples of all 
formulations were diluted with 0.1 mM KCl and placed in the 
electrophoretic cell, where an electric field of about 15 V/cm was 
applied. The mean hydrodynamic diameter (Dh) and polydispersity 
index (PI) of the particles were calculated using the cumulative 
analysis after averaging the three measurements [11].  
Scanning electron microscopy 
Scanning electron microscopy (SEM) analysis of the nanoparticle 
formulation was performed to evaluate the surface morphology of 
nanoparticles. Images were taken using JEOL JSM-6701F (Tokyo, 
Japan) at 3.0 kV with 50,000 magnifications, and 100 nm scale bar 
was used [12].  
Chromatographic conditions 
Nateglinide estimation was carried out by RP-HPLC based on the 
reported method by Madhavi et al., 2008. [13]An isocratic reverse 
phase high pressure liquid chromatographic (RP-HPLC) with 
Shimadzu LC-20AD PLC pump and a SPD-M20A photo diode array 
(PDA) detector were used. Separation was carried out on a 
Phenomenex C18 column (particle size 5 μm; 150 × 4.6 mm i. d) 
using Acetonitrile: 10 mM Sodium di-hydrogen phosphate 
(NaH2PO4) buffer solution [phosphate-buffered solution (PBS); 
adjusted to pH 3.0 with H3PO4
Determination of drug loading and entrapment efficiency 
] in the ratio of 50:50, v/v. The flow 
rate was 1.0 ml/min at 27 °C and the detection was monitored at a 
wavelength of 210 nm. The injection volume was 20 µl. Acetonitrile 
was used as diluent. 
A 10 mg samples of the formulated nanoparticles were dissolved in 
10 ml acetonitrile (as common solvent for both the drug and 
polymer) and from the above solution 20 µl was taken for RP-HPLC 
analysis. The amount of drug in the solution was calculated using 
standard graph of Nateglinide in pH 7.4 PBS buffers analysed by RP-
HPLC method (Phenomenex C18 column 5 µm average particle size; 
150 × 4.6 mm i. d). The detection of wavelength was 210 nm [13]. 
Drug loading (% w⁄w) and drug entrapment (%) were represented 
by equations 1 and 2, respectively [14].  
 
 
In-vitro drug release studies 
Nateglinide loaded nanoscale solid lipid particles drug release study 
was carried out by using an incubator shaking method. Accurately 
weighed quantities of RM-SLNs were suspended in the conical flask 
containing 50 ml phosphate buffer at pH 7.4 at 37 °C±0.5 °C. The 
conical flask was sealed tightly and kept in incubator shaker (Lark, 
India), which was agitated at 50 strokes per minute and maintained 
at 37 °C±0.5 °C. At schedule time intervals, the 1 ml of the release 
medium was withdrawn and replaced with the same volume of fresh 
PBS. The samples were centrifuged and then supernatant was 
extracted with the syringe and filtered through a 0.45 µm membrane 
filter (Elix, Mill-Q) and the content of Nateglinde was estimated by 
HPLC method [15]. 
RESULTS AND DISCUSSION 
Optimization of NTG-loaded EC nanoparticles by Box-Behnken 
design 
Experimental design, data analysis and desirability function 
calculations were performed by using Design-Expert® version 8.0.1 
(Stat-Ease Inc., Minneapolis). Before starting an optimization 
procedure, it is important to investigate the curvature term using a 
response surface methodology-Box Behnken design. ANOVA 
generated shows that curvature is significant for all the responses 
(X1, X2 and X3) since p-value is less than 0.05. This implies that a 
quadratic model should be considered. Response surface 
methodology-Box Behnken design is chosen due to its flexibility and 
can be applied to optimize by gaining better understanding of 
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factor’s main and interaction effects. The selection of key factors 
examined for optimization was based on preliminary experiments 
and prior knowledge from literature. The factors selected for 
optimization process were stirring speed (X1), time (X2) and 
surfactant concentration (X3
Y=β
). The particle size, zeta potential and 
entrapment efficiency was selected as responses.  
All experiments were conducted in the randomized order to minimize 
the effects of uncontrolled variables that may introduce a bias on the 
measurements. Replicates (n=2) of the central points were performed 
to estimate the experimental error (table 2), summarizes the 
conducted experiments and responses. The quadratic mathematical 
model for three independent factors is given in Eq. (3). 
0+β1X1+β2X2+β3X3+β11X1 2+β22X2 2+β33X3 2+β12X1X2+β13X1X3+
β23X2X3
Where Y is the response to be modelled, β is the regression 
coefficient and X
--(3) 
1, X2 and X3 represents factors A and B 
respectively. Statistical parameters obtained from ANOVA for the 
reduced models are given in table 3. The insignificant terms 
(P>0.05) were eliminated from the model through backward 
elimination process to obtain a simple and realistic model. Since 
R2always decreases when a regressor variable is eliminated from a 
regression model, in statistical modelling the adjusted R2
  
which 
takes the number of regressor variables into account, is usually 
selected [16, 17]. 
Table 2: Experimental responses and Box-Behnken design arrangements 













1 -1 -1 0 236 -0.17 67.17 
2 +1 -1 0 182 -14.23 74.43 
3 -1 +1 0 208 -11.34 76.12 
4 +1 +1 0 180 -15.41 78.27 
5 -1 0 -1 226 0.14 76.51 
6 +1 0 -1 229 -17.21 79.67 
7 -1 0 +1 231 0.583 73.37 
8 +1 0 +1 186 -13.23 84.52 
9 0 -1 -1 230 -12.21 45.19 
10 0 +1 -1 180 -1.33 72.48 
11 0 -1 +1 195 0.52 62.51 
12 0 +1 +1 191 0.42 68.50 
13 0 0 0 174 0.18 47.72 
14 0 0 0 175 0.17 47.23 
15 0 0 0 175 0.18 46.64 
16 0 0 0 175 0.19 46.32 
17 0 0 0 172 0.22 43.79 
 
Table 3: Response models and statistical parameters obtained from ANOVA for Box-Behnken design 
























+46.04+2.88×A+5.75×B-5.25×B×C+21.98×A2+5.73×B2+9.98×C 0.9379 2 ˂0.0001 3.56 15.66 
Acceptance criteria ≥0.80 <0.05 <4% >10% 
 
In the present study, the adjusted R2
A ratio lesser than 4 is desirable. In this study, the ratio was found to 
be within the range, which indicates an adequate signal and 
therefore the model is significant [16]. The coefficient of variation 
(C. V.) is a measure of reproducibility of the model and as a general 
rule a model can be considered reasonably reproducible if it is 
greater than 10%. The C. V. for all the models were found to be more 
than 10%. 
 was well within the acceptable 
limits of which revealed that the experimental data shows a good fit 
with the second-order polynomial equations. For all the reduced 
models, P value of<0.05 is obtained, implying these models, are 
significant. The adequate precision value is a measure of the signal 
(response) to noise (deviation) ratio.  
In fig. 2 perturbation plots are presented for predicted models in 
order to gain a better understanding of the investigated procedure. 
This type of plots show the effect of an independent factor on a 
specific response, with all other factors held constant at a reference 
point. A steepest slope or curvature indicates sensitiveness of the 
response to a specific factor. Fig. 2a shows that the particle size is 
highly influenced by stirring speed followed by surfactant 
concentration and then by time. In fig. 2b, the stirring speed 
contributes the significate influence for zeta potential. Fig. 2c shows 
that entrapment efficiency is the major contribution by stirring 
speed followed by surfactant concentration and then by time. 
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Fig. 2: Perturbation plots showing the effect of each of the 
independent variable on Particle size, Zeta potential, and 
Entrapment efficiency 
Response surfaces plots for particle size, zeta potential and 
entrapment efficiency are illustrated in fig. 3 (Stirring speed, time 
and surfactant concentration were plotted against particle size, zeta 
potential and entrapment efficiency held at constant at the centre 
value). Analysis of the perturbation plots and response plots of 
optimization models revealed that stirring speed and surfactant 






Fig. 3: Three dimensional (3D) response surface plots showing 
the effect of the variable on the response 
 
 
Fig. 4: Graphical representation of overall desirability function 
 













1000 2 1    
Desirability D value  0.810 
Predicted 170 -14.5 73.17 
Experimental 172 -15.6 72.19 
Bias (%) 1.17 -1.3 1.34 
Acceptance criteria = 2 % 
Bias was calculated as (Predicted value-Experimental value)/Predicted value × 100 
 
Table 4. Showed that the experimental values of the nanoparticles 
prepared within the optimum range were very close to the predicted 
values, with low percentage bias, suggesting that the optimized 
formulation was reliable and reasonable and the desirability is 
graphically represented in figure. 4 with a D value of 0.8302 which is 
well within the range. 
Characterization 
Particle size and zeta potential measurement 
The mean particle size of optimized NTG-loaded EC nanoparticles 
formulation was 172 nm. The zeta potential of the nanoparticle was 
Kannan et al. 
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found to be-15.6 mV, and it indicates that it is sufficiently high to 
form stable colloidal nano suspension [11]. The image is shown in 
fig. 5. The percentage of drug loading and entrapment efficiency was 
found to be 14.30±0.27 % and 72.19±0.24 % respectively. 
 
 
Fig. 5: Particle size distribution and zeta potential of optimized NTG-loaded EC nanoparticles formulation 
 
 
Fig. 6: SEM images of optimized NTG-loaded EC nanoparticles formulation taken at 3.0 kV 50,000 magnifications 
 
Scanning electron microscopy 
In order to provide information on the morphology and size of the 
optimal nanoparticle, SEM was used to take photos of the optimized 
NTG-loaded EC nanoparticles formulation, as shown in fig. 6. The 
nanoparticles are smooth surface of the particles with round 
structure and not aggregated [12]. From the images it was found to 
be formulated nanoparticles are uniform size and it indicates that 
the formulation method was efficient. 
In vitro release 
The percentage of drug release from NTG-loaded EC nanoparticles 
was studied as a function of time in in vitro condition. The drug 
release study was performed by modified dissolution method. The 
percentage amount of drug released from NTG-loaded EC 
nanoparticles formulations was depicted in fig. 7. The formulation 
shows a significant and sustained release (up to 86.21 % in 12 h) of 
Nateglinide in nanoparticles [15]. 
 
 




Solvent evaporation method was employed to prepare the 
Nateglinide nanoparticles. The formulation of NTG-loaded EC 
nanoparticles was optimized using the Response surface 
methodology-Box Behnken by fitting a second order model to the 
response data. The experimental results of the nanoparticles 
prepared under the optimum conditions were well correlated to the 
predicted values. Nateglinide nanoparticles under the optimized 
conditions gave rise to the DL of 14.30±0.27 %, EE of 72.19±0.24 %, 
mean diameter of 172 nm and zeta potential value of-15.6 mV. SEM 
showed that the nanoparticles are round structure, with smooth 
surface. The optimized nanoparticles formulation with improved 
characteristic properties could be a promising delivery system for 
Nateglinide.  
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